Zeitschriftenartikel zum Thema „Biopsy-based transcriptomics“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Biopsy-based transcriptomics" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Ungar, B., M. Yavzori, E. Fudim, O. Picard, U. Kopylov, R. Eliakim, D. Shouval et al. „P032 Host transcriptome signatures in human fecal-washes predict histological remission in IBD patients“. Journal of Crohn's and Colitis 16, Supplement_1 (01.01.2022): i152—i153. http://dx.doi.org/10.1093/ecco-jcc/jjab232.161.
Der volle Inhalt der QuelleDan, S., B. Ungar, S. Ben-Moshe, K. Bahar Halpern, M. Yavzori, E. Fudim, O. Picard et al. „P017 Fecal wash host transcriptomics identifies inflammation throughout the colon and terminal ileum“. Journal of Crohn's and Colitis 17, Supplement_1 (30.01.2023): i188. http://dx.doi.org/10.1093/ecco-jcc/jjac190.0147.
Der volle Inhalt der QuelleVoutetakis, Konstantinos, Aristotelis Chatziioannou, Efstathios S. Gonos und Ioannis P. Trougakos. „Comparative Meta-Analysis of Transcriptomics Data during Cellular Senescence andIn VivoTissue Ageing“. Oxidative Medicine and Cellular Longevity 2015 (2015): 1–17. http://dx.doi.org/10.1155/2015/732914.
Der volle Inhalt der QuelleDinis Fernandes, Catarina, Annekoos Schaap, Joan Kant, Petra van Houdt, Hessel Wijkstra, Elise Bekers, Simon Linder et al. „Radiogenomics Analysis Linking Multiparametric MRI and Transcriptomics in Prostate Cancer“. Cancers 15, Nr. 12 (06.06.2023): 3074. http://dx.doi.org/10.3390/cancers15123074.
Der volle Inhalt der QuelleCherry, Hannah, Joe Rastrick, Joanna Jacków, Maddy Parsons und John McGrath. „O22 Unravelling the pathophysiology of KLICK syndrome to identify therapeutically targetable pathways“. British Journal of Dermatology 190, Nr. 6 (17.05.2024): e78-e79. http://dx.doi.org/10.1093/bjd/ljae105.022.
Der volle Inhalt der QuelleBoldanova, Tuyana, Geoffrey Fucile, Jan Vosshenrich, Aleksei Suslov, Caner Ercan, Mairene Coto-Llerena, Luigi M. Terracciano et al. „Supervised learning based on tumor imaging and biopsy transcriptomics predicts response of hepatocellular carcinoma to transarterial chemoembolization“. Cell Reports Medicine 2, Nr. 11 (November 2021): 100444. http://dx.doi.org/10.1016/j.xcrm.2021.100444.
Der volle Inhalt der QuelleZhang, Yueyun, Carlos Henrique Venturi Ronchi, Giovanna Ambrosini, Yuanlong Liu, Patrick Aouad, Daria Matvienko, Christoph Merten und Cathrin Brisken. „Abstract PO5-14-06: Transcriptomics-based drug screening in 3D ex vivo patient-drived breast cancer model and patient biopsy for personalized therapy“. Cancer Research 84, Nr. 9_Supplement (02.05.2024): PO5–14–06—PO5–14–06. http://dx.doi.org/10.1158/1538-7445.sabcs23-po5-14-06.
Der volle Inhalt der QuelleCimadamore, Alessia, Silvia Gasparrini, Francesco Massari, Matteo Santoni, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli und Rodolfo Montironi. „Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy“. Cancers 11, Nr. 2 (07.02.2019): 196. http://dx.doi.org/10.3390/cancers11020196.
Der volle Inhalt der QuelleDas, Sreyashi, Mohan Kumar Dey, Ram Devireddy und Manas Ranjan Gartia. „Biomarkers in Cancer Detection, Diagnosis, and Prognosis“. Sensors 24, Nr. 1 (20.12.2023): 37. http://dx.doi.org/10.3390/s24010037.
Der volle Inhalt der Quellevan Bergen, Cornelis A. M., Marvyn T. Koning, Edwin Quinten, Agnieszka Mykowiecka, Julieta Sepulveda, Ramin Monajemi, Ruben A. L. De Groen et al. „High-Throughput BCR Sequencing and Single-Cell Transcriptomics Reveal Distinct Transcriptional Profiles Associated with Subclonal Evolution of Follicular Lymphoma“. Blood 134, Supplement_1 (13.11.2019): 298. http://dx.doi.org/10.1182/blood-2019-130508.
Der volle Inhalt der QuelleKersch, Cymon, Cheryl Claunch, Prakash Ambady, Elmar Bucher, Daniel Schwartz, Ramon Barajas, Jeffrey Iliff, Laura Heiser, Leslie Muldoon und Edward Neuwelt. „PATH-63. TRANSCRIPTIONAL SIGNATURES IN HISTOLOGIC STRUCTURES WITHIN GLIOBLASTOMA TUMORS MAY PREDICT PERSONALIZED TREATMENT SENSITIVITY AND SURVIVAL“. Neuro-Oncology 21, Supplement_6 (November 2019): vi157. http://dx.doi.org/10.1093/neuonc/noz175.658.
Der volle Inhalt der QuelleLee, Irene Tai-Lin, Chin-Hsuan Shen, Feng-Chiao Tsai, Chun-Bing Chen und Kevin Sheng-Kai Ma. „Cancer-Derived Extracellular Vesicles as Biomarkers for Cutaneous Squamous Cell Carcinoma: A Systematic Review“. Cancers 14, Nr. 20 (18.10.2022): 5098. http://dx.doi.org/10.3390/cancers14205098.
Der volle Inhalt der QuelleKretschmer-Kazemi Far, Rosel, Kirsten Frank und Georg Sczakiel. „Sampling, Logistics, and Analytics of Urine for RT-qPCR-based Diagnostics“. Cancers 13, Nr. 17 (30.08.2021): 4381. http://dx.doi.org/10.3390/cancers13174381.
Der volle Inhalt der QuelleCook, Daniel, Dorys Lopez, Anu K. Antony, The SimBioSys Team und John A. Cole. „Multimodal approach to capture spatially resolved single-cell tumor heterogeneity in breast cancer.“ Journal of Clinical Oncology 40, Nr. 16_suppl (01.06.2022): e12597-e12597. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e12597.
Der volle Inhalt der QuelleCook, Daniel, Dorys Lopez, Anu K. Antony, The SimBioSys Team und John A. Cole. „Multimodal approach to capture spatially resolved single-cell tumor heterogeneity in breast cancer.“ Journal of Clinical Oncology 40, Nr. 16_suppl (01.06.2022): e12597-e12597. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e12597.
Der volle Inhalt der QuelleGjyrezi, Ada, Charalampos Skarlis, Paul Zumbo, Doron Betel, Ioanna E. Stergiou, Michael Voulgarelis, Clio P. Mavragani und Paraskevi Giannakakou. „Abstract 1404: Blood-based transcriptomics provides novel insights into Sjögren's syndrome-associated lymphomagenesis“. Cancer Research 84, Nr. 6_Supplement (22.03.2024): 1404. http://dx.doi.org/10.1158/1538-7445.am2024-1404.
Der volle Inhalt der QuelleYohihara, R., H. Tsuchiya, Y. Omata, H. Takahashi, S. Nakajima, H. Mizuhara, A. Uchio et al. „POS1014 INVESTIGATING THE SYNOVIAL PATHOLOGY RELATED TO TREATMENT RESISTANCE IN JAPANESE RHEUMATOID ARTHRITIS PATIENTS USING SINGLE-CELL ANALYSIS“. Annals of the Rheumatic Diseases 82, Suppl 1 (30.05.2023): 823.1–823. http://dx.doi.org/10.1136/annrheumdis-2023-eular.1112.
Der volle Inhalt der QuelleOrsini, Arianna, Chiara Diquigiovanni und Elena Bonora. „Omics Technologies Improving Breast Cancer Research and Diagnostics“. International Journal of Molecular Sciences 24, Nr. 16 (11.08.2023): 12690. http://dx.doi.org/10.3390/ijms241612690.
Der volle Inhalt der QuelleMiller, Dulaney, Kyle Manning, Shuran Xing, T. Jeffrey Cole, Christopher J. Benway, Elena M. Cortizas, J. Christian J. Ray et al. „Stratification of patients with prostate cancer using a comprehensive multiomic approach: Integrating extracellular vesicle transcriptomics profiling with cfDNA methylation in urine-based liquid biopsy.“ Journal of Clinical Oncology 42, Nr. 16_suppl (01.06.2024): e17095-e17095. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.e17095.
Der volle Inhalt der QuelleQuek, Camelia, Aditya Pratapa, Ines Pires da Silva, Ghamdan Al-Eryani, Aaron Mayer, Nenad Bartonicek, Kate Harvey et al. „Abstract 4621: Distinct spatial and molecular maps in the tumour microenvironment of resistant melanoma patients treated with checkpoint inhibitor immunotherapy“. Cancer Research 83, Nr. 7_Supplement (04.04.2023): 4621. http://dx.doi.org/10.1158/1538-7445.am2023-4621.
Der volle Inhalt der QuelleFRENEL, Jean Sebastien, Fadoua Ben Azzouz, Frederic Bigot, Jonathan Dauve, Marie Francoise Heymann, Wilfried Gouraud, Catherine Guette et al. „Abstract P5-02-37: Multi-omics approach to identify markers of resistance to endocrine therapy + CDK4/6 inhibitors in first line HR+/HER2- metastatic breast cancer (MBC) patients“. Cancer Research 83, Nr. 5_Supplement (01.03.2023): P5–02–37—P5–02–37. http://dx.doi.org/10.1158/1538-7445.sabcs22-p5-02-37.
Der volle Inhalt der QuelleNeagu, Anca-Narcisa, Danielle Whitham, Pathea Bruno, Hailey Morrissiey, Celeste A. Darie und Costel C. Darie. „Omics-Based Investigations of Breast Cancer“. Molecules 28, Nr. 12 (14.06.2023): 4768. http://dx.doi.org/10.3390/molecules28124768.
Der volle Inhalt der QuelleChang, Ming-Ling, und Sien-Sing Yang. „Metabolic Signature of Hepatic Fibrosis: From Individual Pathways to Systems Biology“. Cells 8, Nr. 11 (12.11.2019): 1423. http://dx.doi.org/10.3390/cells8111423.
Der volle Inhalt der QuelleDu, Mulong. „Prospective of Mitochondrial DNA Variations in Cancer on Genomic Medicine“. Cancer Epidemiology, Biomarkers & Prevention 33, Nr. 6 (03.06.2024): 766–68. http://dx.doi.org/10.1158/1055-9965.epi-24-0233.
Der volle Inhalt der QuelleReis Nisa, P. I., C. Mahony, C. Smith, C. D. Buckley, K. Raza, A. Filer, D. Windell, M. Coles und A. Croft. „OP0094 SPATIAL POSITIONING AND MATRIX PROGRAMS OF SYNOVIAL FIBROBLASTS UNDERPIN IMMUNE CELL ORGANISATION AND SYNOVIAL TISSUE PATHOTYPE“. Annals of the Rheumatic Diseases 82, Suppl 1 (30.05.2023): 64.2–64. http://dx.doi.org/10.1136/annrheumdis-2023-eular.6114.
Der volle Inhalt der QuelleLin, Pei-Hsuan, Wan-Ping Su, Chia-Jung Li, Li-Te Lin, Jim Jinn-Chyuan Sheu, Zhi-Hong Wen, Jiin-Tsuey Cheng und Kuan-Hao Tsui. „Investigating the Role of Ferroptosis-Related Genes in Ovarian Aging and the Potential for Nutritional Intervention“. Nutrients 15, Nr. 11 (25.05.2023): 2461. http://dx.doi.org/10.3390/nu15112461.
Der volle Inhalt der QuelleSitnikova, Suzanne Isabelle, Sophie Munnings-Tomes, Elena Galvani, Stacy Kentner, Kathy Mulgrew, Chris Rands, Judit España Agustí et al. „Novel non-terminal tumor sampling procedure using fine needle aspiration supports immuno-oncology biomarker discovery in preclinical mouse models“. Journal for ImmunoTherapy of Cancer 9, Nr. 6 (Juni 2021): e002894. http://dx.doi.org/10.1136/jitc-2021-002894.
Der volle Inhalt der QuelleImai, Mitsuho, Jinyeong Lim, Naoko Iida, Hiromichi Ebi, Wataru Okamoto, Takeshi Kato, Taito Esaki et al. „Deciphering tumor microenvironment dynamics in HER2-amplified refractory metastatic colorectal cancer in the TRIUMPH trial.“ Journal of Clinical Oncology 42, Nr. 16_suppl (01.06.2024): 3564. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.3564.
Der volle Inhalt der QuelleNaing, Aung, Hirva Mamdani, Minal A. Barve, Melissa Lynne Johnson, Sam Darko, Julie A. Murphy, Lauren Trogun et al. „Investigation of a potential protein biomarker signature that may predict clinical benefit of NT-I7 and pembrolizumab in patients with cold gastrointestinal tumors.“ Journal of Clinical Oncology 42, Nr. 16_suppl (01.06.2024): 2563. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.2563.
Der volle Inhalt der QuelleTesfaye, D., N. Ghanem, F. Rings, E. Tholen, C. Phatsara, K. Schellander und M. Hoelker. „196 EMBRYO BIOPSY TRANSCRIPTOMICS: A POTENTIAL TOOL TO IDENTIFY TRANSCRIPTS DIRECTLY RELATED TO THE ABILITY OF THE EMBRYO TO INDUCE PREGNANCY AFTER TRANSFER“. Reproduction, Fertility and Development 21, Nr. 1 (2009): 196. http://dx.doi.org/10.1071/rdv21n1ab196.
Der volle Inhalt der QuelleBojmar, Linda, Constantinos P. Zambirinis, Jonathan Hernandez, Jayasree Chakraborty, Samer Hanna, Diane Simeone, David Kelsen et al. „Abstract PR012: Perioperative liver biopsy captures features of the liver pre-metastatic niche and predicts metastatic outcome after pancreatic cancer resection“. Cancer Research 82, Nr. 22_Supplement (15.11.2022): PR012. http://dx.doi.org/10.1158/1538-7445.panca22-pr012.
Der volle Inhalt der QuelleTreaba, Diana O., Dennis M. Bonal, Anna D. Chorzalska, Christoph Schorl, Kelsey Hopkins, John L. Reagan, Peter Rintels, Peter J. Quesenberry und Patrycja M. Dubielecka. „Levels of Osteopontin (SPP1), Osteonectin (SPARC) and Biglycan (BGN) in Acute Myeloid Leukemia Bone Marrow Biopsies Post-Induction Therapy Define the Status of Osteogenic Niche and Show Inverse Correlation with Therapeutic Response“. Blood 136, Supplement 1 (05.11.2020): 29–30. http://dx.doi.org/10.1182/blood-2020-142604.
Der volle Inhalt der QuelleNikfar, Mehdi, Haoyang Mi, Chang Gong, Holly Kimko und Aleksander S. Popel. „Quantifying Intratumoral Heterogeneity and Immunoarchitecture Generated In-Silico by a Spatial Quantitative Systems Pharmacology Model“. Cancers 15, Nr. 10 (13.05.2023): 2750. http://dx.doi.org/10.3390/cancers15102750.
Der volle Inhalt der QuelleClemenceau, Jean R., Paola Suarez Meade, Mark E. Jentoft, Alfredo Quiñones-Hinojosa und Tae Hyun Hwang. „Abstract 144: Spatial transcriptomic landscape of the primary and recurrent glioblastoma tumor microenvironment“. Cancer Research 83, Nr. 7_Supplement (04.04.2023): 144. http://dx.doi.org/10.1158/1538-7445.am2023-144.
Der volle Inhalt der QuelleAnderson, Chiron J., und Stephan Schmitz-Esser. „41 Differential Gene Expression of the Bovine Rumen Epithelial Microbiota During a Sub-acute Ruminal Acidosis (SARA) Challenge“. Journal of Animal Science 100, Supplement_2 (12.04.2022): 12. http://dx.doi.org/10.1093/jas/skac064.018.
Der volle Inhalt der QuelleLopez-Escalera, Silvia, Mari L. Lund, Gerben D. A. Hermes, Béatrice S. Y. Choi, Kei Sakamoto und Anja Wellejus. „In Vitro Screening for Probiotic Properties of Lactobacillus and Bifidobacterium Strains in Assays Relevant for Non-Alcoholic Fatty Liver Disease Prevention“. Nutrients 15, Nr. 10 (18.05.2023): 2361. http://dx.doi.org/10.3390/nu15102361.
Der volle Inhalt der QuelleKugler, M., M. Dellinger, F. Kartnig, L. Müller, T. Preglej, L. Heinz, E. Simader et al. „AB0056 CYTOKINE-DIRECTED CELLULAR CROSSTALK IMPRINTS SYNOVIAL PATHOTYPES IN RHEUMATOID ARTHRITIS“. Annals of the Rheumatic Diseases 82, Suppl 1 (30.05.2023): 1207.2–1207. http://dx.doi.org/10.1136/annrheumdis-2023-eular.6440.
Der volle Inhalt der QuelleRing, Alexander, Daniel Campo, Tania B. Porras, Pushpinder Kaur, Victoria A. Forte, Debu Tripathy, Janice Lu et al. „Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast Cancer“. Annals of Surgical Oncology 29, Nr. 5 (09.01.2022): 2882–94. http://dx.doi.org/10.1245/s10434-021-11135-2.
Der volle Inhalt der QuelleChen, L., C. Zhang, R. Niu, R. Mao, Y. Qiu und R. Feng. „P915 Multi-Omics Biomarkers for the Prediction of Response to Biologics in Patients with Inflammatory Bowel Disease“. Journal of Crohn's and Colitis 18, Supplement_1 (01.01.2024): i1670—i1671. http://dx.doi.org/10.1093/ecco-jcc/jjad212.1045.
Der volle Inhalt der QuellePatil, Madhuri. „What is the Optimum Endometrium Needed for Implantation?“ Fertility & Reproduction 05, Nr. 04 (Dezember 2023): 290. http://dx.doi.org/10.1142/s2661318223741048.
Der volle Inhalt der QuelleYu, Liping. „Abstract 1393: A Novel platform providing automated, consistent and gentle cell isolation from tissues for downstream applications“. Cancer Research 82, Nr. 12_Supplement (15.06.2022): 1393. http://dx.doi.org/10.1158/1538-7445.am2022-1393.
Der volle Inhalt der QuelleBahrambeigi, Vahid, Jaewon J. Lee, Kimal I. Rajapakshe, Bret M. Stephens, Jason T. Henry, Sarah Dhebat, Mark W. Hurd et al. „Abstract PR013: Transcriptomic profiling of liquid biopsy in colorectal cancer“. Cancer Research 82, Nr. 23_Supplement_1 (01.12.2022): PR013. http://dx.doi.org/10.1158/1538-7445.crc22-pr013.
Der volle Inhalt der QuelleIwamoto, F., O. Al Dalahmah, K. Manjrekar, C. Levrero, R. Michel, A. Bargo, S. Kaesshaefer et al. „P11.82.A TARGETING THE GLIOBLASTOMA MASTER REGULATOR C/EBPß: A PHARMACOKINETIC AND PHARMACODYNAMIC NEOADJUVANT STUDY OF ST101“. Neuro-Oncology 25, Supplement_2 (01.09.2023): ii95. http://dx.doi.org/10.1093/neuonc/noad137.316.
Der volle Inhalt der QuelleHasanov, Elshad, Lesley Flynt, Rebecca Tidwell, Hyunsoo Hwang, Roserika Brooks, Lauren Michelle Wood, Travis Solley et al. „Phase 1b/2 study of combination 177Lu girentuximab plus cabozantinib and nivolumab in treatment naive patients with advanced clear cell RCC.“ Journal of Clinical Oncology 42, Nr. 4_suppl (01.02.2024): TPS496. http://dx.doi.org/10.1200/jco.2024.42.4_suppl.tps496.
Der volle Inhalt der QuelleJonasch, Eric, Elshad Hasanov, Lesley Flynt, Hyunsoo Hwang, Rebecca Slack Tidwell, Roserika Brooks, Lauren Michelle Wood et al. „Phase 1b/2 study of combination 177Lu girentuximab plus cabozantinib and nivolumab in treatment naive patients with advanced clear cell RCC.“ Journal of Clinical Oncology 42, Nr. 16_suppl (01.06.2024): TPS4610. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.tps4610.
Der volle Inhalt der QuelleCampbell, Katie M., Zaid Bustami, Daniel G. Chen, Egmidio Medina, Cynthia R. Gonzalez, Nataly Naser Aldeen, Ignacio Baselga-Carretero et al. „Abstract 6550: Biopsy analysis of trial S1616: Ipilimumab plus nivolumab versus ipilimumab alone in patients with anti-PD-1 refractory melanoma“. Cancer Research 84, Nr. 6_Supplement (22.03.2024): 6550. http://dx.doi.org/10.1158/1538-7445.am2024-6550.
Der volle Inhalt der QuelleGenta, Sofia, Ming Sound Tsao, Ben X. Wang, Aaron Richard Hansen, Trevor John Pugh, Mathieu Lupien, Bryan Coburn et al. „Immune Resistance Interrogation Study (IRIS): A prospective comprehensive multi-omic analysis in patients with intrinsic and acquired resistance to immunotherapy.“ Journal of Clinical Oncology 39, Nr. 15_suppl (20.05.2021): TPS2679. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.tps2679.
Der volle Inhalt der QuelleHasanov, Elshad, Lesley Flynt, Rebecca Slack Tidwell, Hyunsoo Hwang, Roserika Brooks, Lauren Michelle Wood, Travis Solley et al. „Phase 1b/2 study of combination 177Lu girentuximab plus cabozantinib and nivolumab in treatment naïve patients with advanced clear cell RCC.“ Journal of Clinical Oncology 41, Nr. 16_suppl (01.06.2023): TPS4605. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.tps4605.
Der volle Inhalt der QuelleHasanov, Elshad, Lesley Flynt, Rebecca Slack Tidwell, Hyunsoo Hwang, Roserika Brooks, Lauren Michelle King, Travis Solley et al. „Phase 1b/2 study of combination 177Lu girentuximab plus cabozantinib and nivolumab in treatment naïve patients with advanced clear cell RCC.“ Journal of Clinical Oncology 41, Nr. 6_suppl (20.02.2023): TPS749. http://dx.doi.org/10.1200/jco.2023.41.6_suppl.tps749.
Der volle Inhalt der QuelleHasanov, Elshad, Lesley Flynt, Rebecca Slack Tidwell, Hyunsoo Hwang, Roserika Brooks, Lauren King, Travis Solley et al. „STARLITE 1: Phase 1b/2 study of combination 177Lu girentuximab plus cabozantinib and nivolumab in treatment naïve patients with advanced clear cell RCC“. Oncologist 28, Supplement_1 (23.08.2023): S13. http://dx.doi.org/10.1093/oncolo/oyad216.021.
Der volle Inhalt der Quelle